Management of hypertension in pregnancy

被引:7
作者
Brown, MA [1 ]
Whitworth, JA
机构
[1] Univ New S Wales, St George Hosp, Dept Renal Med, Kogarah, NSW 2217, Australia
[2] Univ New S Wales, St George Hosp, Dept Med, Kogarah, NSW 2217, Australia
关键词
pre-eclampsia; eclampsia; white-coat Hypertension; gestational hypertension; placenta; methyldopa; oxprenolol; hydralazine; magnesium; volume expansion;
D O I
10.3109/10641969909061019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hypertension in pregnancy is generally defined as either an absolute BP greater than or equal to 140/90 mm Hg or a rise in systolic BP greater than or equal to 25 mm Hg and/or diastolic BP greater than or equal to 15 mm Hg from pre-conception or 1(st) trimester BP. Hypertension in pregnancy is classified as: a) Chronic - essential or secondary hypertension, b) De novo - pre-eclampsia or gestational hypertension, and c) Pre-eclampsia superimposed on chronic hypertension. Pre-eclampsia is a multisystem disorder in which hypertension is but one sign. The major maternal abnormalities occur in kidneys, liver, brain and coagulation systems. Impaired uteroplacental blood flow causes fetal growth retardation or intrauterine death. There is general agreement that BP greater than or equal to 170/110 mm Hg should be lowered rapidly to protect the mother against risk of stroke or eclampsia. There is dispute concerning the level at which lesser degrees of hypertension should be treated, and lowering BP is treating only one aspect of pre-eclampsia. Delivery remains the definitive management.
引用
收藏
页码:907 / 916
页数:10
相关论文
共 47 条
[1]  
[Anonymous], 1990, AM J OBSTET GYNECOL, V163, P1691
[2]  
ARE ACE, 1989, LANCET, V2, P482
[3]  
BEROYZ G, 1994, LANCET, V343, P619
[4]  
BRENNECKE SP, 1995, AUST NZ J OBSTET GYN, V35, P38
[5]   INADEQUACY OF DIPSTICK PROTEINURIA IN HYPERTENSIVE PREGNANCY [J].
BROWN, MA ;
BUDDLE, ML .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1995, 35 (04) :366-369
[6]   Hypertension in pregnancy: Maternal and fetal outcomes according to laboratory and clinical features [J].
Brown, MA ;
Buddle, ML .
MEDICAL JOURNAL OF AUSTRALIA, 1996, 165 (07) :360-365
[7]   What's in a name? Problems with the classification of hypertension in pregnancy [J].
Brown, MA ;
Buddle, ML .
JOURNAL OF HYPERTENSION, 1997, 15 (10) :1049-1054
[8]   Randomised trial of management of hypertensive pregnancies by Korotkoff phase IV or phase V [J].
Brown, MA ;
Buddle, ML ;
Farrell, T ;
Davis, G ;
Jones, M .
LANCET, 1998, 352 (9130) :777-781
[9]   THE PHYSIOLOGY OF PREECLAMPSIA [J].
BROWN, MA .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1995, 22 (11) :781-791
[10]   Is it safe to withhold convulsion prophylaxis in preeclamptic women without neurological features? [J].
Brown, MA ;
Buddle, HL .
HYPERTENSION IN PREGNANCY, 1998, 17 (01) :13-21